Added to YB: 2025-11-11
Pitch date: 2025-11-07
HIMS [neutral]
Hims & Hers Health, Inc.
-13.26%
current return
Author Info
Asymmetric Investing analyzes stocks that have an asymmetric return potential of 10x (or more) over the next decade. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$42.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
growth
Hims & Hers: Taking the Long-Term View
HIMS (earnings): Q3'25 revenue +49% YoY, adj EBITDA +53%. Expanding beyond 'hair & ED' into GLP-1/GIP treatments, whole-genome sequencing, longevity platform launching 2026. Vertical integration with 1M+ sq ft FDA facilities cuts costs. International expansion to Canada, Brazil, UK. Tracking toward $6.5B rev/$1.3B EBITDA 2030 targets.
Read full article (4 min)